Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-050027)

Filing Details

Accession Number:: 0001140361-11-050027
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-21 16:41:56
Reporting Period:: 2011-10-03

Filing Date:: 2011-10-21
Accepted Time:: 2011-10-21 16:41:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1228627	Rexahn Pharmaceuticals Inc.	RNN	Pharmaceutical Preparations (2834)	113516358

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503757	Richard Kivel	C/O Rexahn Pharmaceuticals 15245 Shady Grove Road, Suite 455 Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-03	2,500	$1.04	2,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right-to-buy)	$1.25		2021-06-06	20,000	20,000	Direct
Common Stock	Stock Options (right-to-buy)	$1.19	2011-09-17	2010-09-17	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-06-06	20,000	20,000	Direct
2010-09-17	20,000	20,000	Direct

Footnotes

These options vest and become exercisable in full on June 6, 2012.